Sensitive ASX Announcement

Clinuvel - positive results from pivotal Phase III EPP study

Published: 20/12/11, 08:27am (AEST)3 pages
Clinuvel Pharmaceuticals Limited
CUV:ASXHealthcare

Recent CUV Announcements

Price Sensitive only